{"id":"NCT03902080","sponsor":"Urovant Sciences GmbH","briefTitle":"Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)","officialTitle":"A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-26","primaryCompletion":"2023-06-15","completion":"2023-06-15","firstPosted":"2019-04-03","resultsPosted":"2024-08-07","lastUpdate":"2024-08-07"},"enrollment":1105,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Overactive Bladder"],"interventions":[{"type":"DRUG","name":"Vibegron","otherNames":["RVT-901","MK-4618","KRP-114V","URO-901"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Vibegron 75 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.","primaryOutcome":{"measure":"Change From Baseline at Week 12 in the Average Number of Micturition Episodes Per Day","timeFrame":"Baseline; Week 12","effectByArm":[{"arm":"Vibegron 75 Milligrams (mg) Once Daily (QD)","deltaMin":-2.04,"sd":0.109},{"arm":"Placebo","deltaMin":-1.3,"sd":0.109}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"45 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":140,"countries":["United States","Belgium","Canada","Hungary","Lithuania","Poland","Portugal","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":24,"n":553},"commonTop":["Hypertension","COVID-19","Urinary tract infection","Haematuria"]}}